IVF clinics aren’t created equal - the cost of IVF

Cost of IVFOver the weekend, media reported on the cost of IVF and compared offerings between premium clinics and low cost IVF providers. We want to clarify the difference between the two and provide readers with some more insight.
 
Selecting the right fertility clinic can be overwhelming. There is a lot of information to understand and it can be hard to compare what clinics offer and what elements matter most. But, it’s one of the most important decisions you’ll make for your family because selecting the right clinic can impact your chance of success.
 
With the range of clinics available it can be easy to compare on cost alone however there are a number of other factors that are equally, if not more important and that ultimately impact the final cost it takes to create a family.
 
When it comes to fertility treatment, you get what you pay for. At Genea, we believe it is imperative to invest in and offer world leading care and technology. Ultimately, we work to ensure we offer patients the best chance of a family as quickly as possible. We employ highly trained scientists, nurses and counsellors who are all critical to a successful and high care outcome.
 
Care is an essential element to treatment. Genea Fertility Specialists take time to listen to patients, correctly diagnose the cause of infertility and implement personalised treatment plans in response.  As a result, 50% of patients who see a Genea Fertility Specialist, don’t require IVF- presenting a significant cost saving to patients and Medicare. Annual surveys of our patients consistently shows 8/10 patients who started treatment elsewhere wish they came to Genea first, again reflecting our premium care and outcomes^.
 
As for technology, it is also essential- we are proud to invest heavily into research and development, which has led to the development of Genea exclusive technologies in our laboratory that maximise patients’ chance of taking home a baby. This means that patients who are destined to conceive in IVF will do so faster. At Genea, our world class science and processes aim to help patients complete their family in just one cycle. We aim to do one egg and sperm collection and from this one stimulation cycle, create enough good quality embryos for patients to complete their family. It’s the egg collection, with the hormone injections and procedure - that is the greatest impost to the woman. In contrast, the subsequent use of frozen embryos is simple, often drug free and less expensive than egg collection procedures. At Genea 59% of patients who achieved a live birth and returned for a frozen transfer have had a second child with just the one initial stimulated IVF cycle*. Not all clinics aspire to one cycle, one family.
 
ANZARD data published in 2017, found clinics’ success rates range from 12% to 36% (live birth, all ages) in Australia and New Zealand, revealing different clinics deliver different outcomes. These outcomes are driven by the quality of the care and technology. One in 4 patients come to us from other clinics after being unsuccessful elsewhere^^. Our Genea developed Geri incubation system, has seen an increase of 46.7% in the number of high grade embryos per cycle compared to the traditional culture medium system**. And Geri facilitates Grow- our Australian first app allowing patients to view their embryos during the six days they spend growing in the lab- greatly enhancing the patient experience. Every single patient at Genea has access to this technology as a standard inclusion to our premium offering.
 
There is a difference between IVF clinics, Genea is a premium service that is proud to invest in technology maximising a patients chance of having a family in the least number of stimulated cycles with leading care to support couples on their journey.


 
^ Of those patients who responded to the Genea patient survey conducted between 1 January 2017 and 31 December 2017 (223 patients)
 
*1st Stim Cycle between 01Jan12-31Dec13 (3573 patients). Following subsequent Cryos through to 31Dec15. Autologous patients only (no donor oocytes or surrogates). Sites from Kent St, Liverpool, Canberra, Norwest/Bella Vista, Illawarra. Oocyte Vitrification patients excluded

^^Based on a subset of patients who had their first egg collection at Genea in 2012
 
** Study performed at Genea’s flagship Kent Street, Sydney CBD laboratory. Data presented at Fertility Society of Australia Conference, October 2017. Adelaide.
Posted: 24/04/2018 4:34:07 PM by Karen Sivieng | with 0 comments
Comments
Blog post currently doesn't have any comments.
 Security code
RSS 2.0